Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b) On September 2, 2008, Jerrold D. Dotson resigned from his positions as Vice
President-Finance and Administration (principal financial and accounting
officer) and Secretary of Calypte Biomedical Corporation (the "Company") to
pursue other opportunities. Mr. Dotson will remain with the Company as a
consultant until such time as the Company appoints a permanent Chief Financial
Officer. In the interim, Donald N. Taylor, the Company's President and Chief
Executive Officer, will serve as interim Chief Financial Officer. There were no
disagreements between the Company and Mr. Dotson.
Add
CBMC.OB to Portfolio
Set Alert
Email to a
Friend